Katie Verdin, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2509 Lee Dr, Pierre Part, LA 70339 Phone: 985-518-5927 |
News Archive
Cubist Pharmaceuticals, Inc. today announced the commencement of its tender offer for all outstanding shares of the common stock of Adolor Corporation for $4.25 per share in cash, plus one nontransferable Contingent Payment Right entitling the holder to receive additional cash payments of up to $4.50 for each share tendered if certain regulatory approvals and/or commercialization milestones for ADL5945 are achieved.
Gillen Washington, a student at Northern Arizona University, had been getting medication for an immunodeficiency disease since 2011. But when he went to his clinic in November 2014 for the monthly dose, a nurse told him his insurance company had denied it.
As the XV International AIDS Conference currently on in Bangkok brings global attention on the HIV/AIDS epidemic, UNAIDS India has launched a new website on HIV/AIDS in India.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present new pre-clinical data on its oncology compound RX-3117 during a poster session at the American Association for Cancer Research (AACR) 103rd Annual Meeting being held in Chicago, Illinois, March 31 - April 4, 2012, at the McCormick Place Convention Center.
› Verified 4 days ago